Survival differences and trends in patients with AIDS in the United States.
The AIDS surveillance system maintained by the Centers for Disease Control and Prevention (CDC) provides a unique data base for estimating survival after a diagnosis of AIDS for the general AIDS population in the United States. Because patients enrolled in most AIDS clinical trial studies receive unusual medical care that may not be available to the general public and typically have relatively longer survival time, estimates obtained from these studies may not be of direct use in assessing the national health-care needs. Furthermore, such studies are usually of short duration and may not be very informative for long-term health-policy planning. We present survival estimates obtained from the CDC surveillance data for the adult/adolescent AIDS population in the United States and compare their survival and trend in survival on gender, sexual behavior, and injection-drug use status. These estimates provide information for mortality risk after an AIDS diagnosis over a period of 8 years and for trend of survival during the period between 1983 and 1991.
Tu
X M
XM
Department of Mathematics and Statistics, University of Pittsburgh, Pennsylvania.
Meng
X L
XL
Pagano
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000150:complications; D016016:Proportional Hazards Models; D012307:Risk Factors; D012725:Sexual Behavior; D015819:Substance Abuse, Intravenous / Q000150:complications; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine